Graves’ Disease Market Size, Share, Analysis, Industry Report and Forecast 2021-2027
The global graves’ disease market is anticipated to grow at a considerable CAGR of 4.2% during the forecast period (2021-2027). The market growth is mainly driven by growing demand for graves’ disease treatment owing to the growing prevalence of thyroid disorder, rising iodine disorder, and technological advancement among others. As per the world health organization (WHO), around 20 million Americans suffer from thyroid diseases across the US. World health organization (WHO) along with the American Association of Clinical Endocrinologists (AACE) also had highlighted the fact that effective thyroid therapeutics for treatment are demanded to fight and win against this disease.
To Request a Sample of our Report on Graves’ Disease
Market: https://www.omrglobal.com/request-sample/graves-disease-market
Additionally, favorable
reimbursement policies with strategic initiatives for the treatment of Graves
diseases are further augmenting the growth and development of the market. For
instance, in January 2020, Horizon Therapeutics plc along with one of the
oldest volunteer eye health organizations Prevent blindness had launched an
initiative for encouraging and motivating people who are having graves’
diseases to focus on eye health as well. This was done in the awareness month
of graves diseases to focus on eye health by recognizing the symptoms of a
separate, but related disease called Thyroid Eye Disease (TED) as Up to half of
people with Graves’ disease will develop TED so taking care of it is a must.
(Get
15% Discount on Buying this Report)
A
full Report of Graves, Disease Market is Available at: https://www.omrglobal.com/industry-reports/graves-disease-market
Market Coverage
·
The market number
available for – 2020-2027
·
Base year- 2020
·
Forecast period-
2021-2027
Segment Covered-
·
By
Diagnosis
·
By Treatment
Regions Covered-
·
North
America
·
Europe
·
Asia-Pacific
·
Rest of the World
·
Competitive
Landscape- GlaxoSmithKline plc, Abbott Laboratories, Pfizer Inc., Macleods
Pharmaceuticals Ltd., and EpiVax, Inc.
By Diagnosis
·
Ultrasound
·
Imaging
Tests
·
Radioactive
Iodine Uptake
·
Blood
Sample
By Treatment
·
Antithyroid
medication
·
Radioactive
iodine therapy
·
Surgery
Regional
Analysis
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
China
·
India
·
Japan
·
South
Korea
·
Rest of
Asia-Pacific
Rest of the
World
·
Latin
America
·
Middle
East & Africa
Company Profiles
·
AbbVie Inc.
·
Abbott Laboratories
·
Acella Pharmaceuticals, LLC
·
Allergan PLC
·
ApitopeInternational N.V.
·
AstraZeneca PLC
·
Bayer AG
·
Biomérieux S.A.
·
East West Pharma
·
EpiVax, Inc.
·
F.Hoffman-La-Roche AG
·
GlaxoSmithKline plc.
·
Lupin, Ltd.
·
Macleods Pharmaceuticals Ltd.
·
Merck KGaA
·
Mylan N.V.
·
Novartis International AG
·
Pfizer Inc.
·
RLC Labs
·
Sanofi S.A.
·
Takeda Pharmaceutical Co.Ltd.
· Torrent Pharmaceuticals, Ltd.
Reasons to Buying From us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/graves-disease-market
About Orion
Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports, consulting
and other research-based services.
For More Information, Visit Orion
Market Research
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment